Intervention studies and antimicrobial resistance in Italy: An overview of the latest evidence
Year: 2026
Type: article
Abstract: OBJECTIVE: Antimicrobial resistance (AMR) poses a significant and growing threat to public health globally, with Italy facing some of the highest resistance rates in Europe. This manuscript reviewed recent Italian intervention studies aimed at mitigating AMR across bacterial, fungal, and viral domains. METHODS: Strategies including antimicrobial stewardship (AMS), infection prevention and control (IPC), antifungal stewardship (AFS), and diagnostic advancements were evaluated. The evidence highlighted both the promise and limitations of Italy's current approach. RESULTS: While AMS and IPC programs have reduced antibiotic use, healthcare-associated infections, and costs, regional disparities, inconsistent implementation, and limited longitudinal surveillance remain critical challenges. The fungal resistance landscape is marked by rising threats like Candida auris, requiring urgent expansion of AFS programs. Italy's AMR strategy would benefit from improved IPC infrastructure, realtime data integration, and alignment with One Health principles. CONCLUSIONS: Strengthening national coordination, supportinginnovation, and translating surveillance into action at the local level are crucial for turning policy into measurable progress. This review provides actionable insights to guide a more unified and responsive national AMR framework.
Institutions: Ministero della Salute, Istituto Superiore di Sanità, AREA Science Park, Università Cattolica del Sacro Cuore, Vita-Salute San Raffaele University, Link Campus University, University of Campania "Luigi Vanvitelli", World Health Organization Regional Office for Europe, World Health Organization - Denmark, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Siena, Ospedale Santa Maria alle Scotte, Azienda Ospedaliera Universitaria Senese, Ospedale Policlinico San Martino
Language: English
Subfield: Applied Microbiology and Biotechnology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $1,890
OpenAlex ID: W7119489045
